Lazard Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619K | Sell |
|
|||||
|
2025
Q1 | $8.32M | Buy |
|
|||||
|
2024
Q4 | $5.98M | Buy |
|
|||||
|
2024
Q3 | $5.03M | Buy |
|
|||||
|
2024
Q2 | $2.27M | Buy |
|
|||||
|
2024
Q1 | $730K | Buy |
|
|||||
|
2023
Q4 | $474K | Buy |
|
|||||
|
2023
Q3 | $370K | Buy |
|
|||||
|
2023
Q2 | $314K | Buy |
|
|||||
|
2023
Q1 | $258K | Hold |
|
|||||
|
2022
Q4 | $302K | Hold |
|
|||||
|
2022
Q3 | $189K | Hold |
|
|||||
|
2022
Q2 | $154K | Buy |
|
|||||
|
2022
Q1 | $85K | Buy |
|
|||||
|
2021
Q4 | $55K | Buy |
|